Yitshak Zohar
Overview
Explore the profile of Yitshak Zohar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minocha E, Jiang L, Gupta A, Green R, Zohar Y, Wertheim J
Gastro Hep Adv
. 2025 Feb;
4(4):100601.
PMID: 39996239
No abstract available.
2.
Jiang L, Khawaja H, Tahsin S, Clarkson T, Miranti C, Zohar Y
Front Bioeng Biotechnol
. 2024 Nov;
12:1520130.
PMID: 39600890
[This corrects the article DOI: 10.3389/fbioe.2024.1302223.].
3.
Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B, et al.
Oncogene
. 2024 Nov;
44(1):50.
PMID: 39511413
No abstract available.
4.
Szewczyk K, Jiang L, Khawaja H, Miranti C, Zohar Y
Micromachines (Basel)
. 2024 Oct;
15(10).
PMID: 39459070
Prostate cancer is a disease in which cells in the prostate, a gland in the male reproductive system below the bladder, grow out of control and, among men, it is...
5.
Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B, et al.
Oncogene
. 2024 May;
43(27):2092-2103.
PMID: 38769192
Androgen Receptor (AR) activity in prostate stroma is required to maintain prostate homeostasis. This is mediated through androgen-dependent induction and secretion of morphogenic factors that drive epithelial cell differentiation. However,...
6.
Jiang L, Khawaja H, Tahsin S, Clarkson T, Miranti C, Zohar Y
Front Bioeng Biotechnol
. 2024 Feb;
12:1302223.
PMID: 38322789
Lack of adequate models significantly hinders advances in prostate cancer treatment, where resistance to androgen-deprivation therapies and bone metastasis remain as major challenges. Current models fail to faithfully mimic the...
7.
Tello J, Jiang L, Zohar Y, Restifo L
Neural Dev
. 2023 Oct;
18(1):6.
PMID: 37805506
Background: CASK-related neurodevelopmental disorders are untreatable. Affected children show variable severity, with microcephaly, intellectual disability (ID), and short stature as common features. X-linked human CASK shows dosage sensitivity with haploinsufficiency...
8.
Liu B, Wang X, Jiang L, Xu J, Zohar Y, Yao G
Front Cell Dev Biol
. 2022 Mar;
10:792719.
PMID: 35281101
The balance between cell quiescence and proliferation is fundamental to tissue physiology and homeostasis. Recent studies have shown that quiescence is not a passive and homogeneous state but actively maintained...
9.
Frankman Z, Jiang L, Schroeder J, Zohar Y
Micromachines (Basel)
. 2022 Feb;
13(2).
PMID: 35208277
Cancer is a disease in which cells in the body grow out of control; breast cancer is the most common cancer in women in the United States. Due to early...
10.
Frost T, Jiang L, Zohar Y
Micromachines (Basel)
. 2020 May;
11(5).
PMID: 32466113
As the range of applications of organs-on-chips is broadening, the evaluation of aerosol-based therapies using a lung-on-a-chip model has become an attractive approach. Inhalation therapies are not only minimally invasive...